Literature DB >> 2293663

Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells.

B Chesebro1, R Buller, J Portis, K Wehrly.   

Abstract

CD4 molecules on human cells function as a major receptor for human immunodeficiency virus (HIV); however, certain CD4-negative cell types may also be susceptible to infection. Therefore, we attempted to quantitate the relationship between HIV infection and CD4 expression on human cell lines before and after introduction of the CD4 gene by using a retrovirus vector. Prior to introduction of the CD4 expression vector, low levels of HIV infection were detected by a sensitive focal immunoassay on all three cell types studied. With several HIV strains in clones of human cervical carcinoma (HeLa) cells expressing different levels of CD4, HIV titer increased with increasing CD4 expression. In contrast, in squamous cell carcinoma cells (SCL1) and astroglial cells (U87MG), even high levels of CD4 expression failed to augment HIV infection. The CD4 protein expressed in these two cell lines had the expected molecular weight and was capable of binding HIV virions. However, in contrast to CD4-positive HeLa cells, CD4-positive U87MG and SCL1 cells were unable to form syncytia when cultured with cells expressing HIV envelope protein. Thus, the inability of HIV to infect these cells appeared to be due to lack of fusion between HIV virion envelope proteins and CD4-positive cell membranes. This block is infectivity was overcome when cells were infected with HIV which was pseudotyped with the envelope protein of amphotropic murine leukemia virus. Thus, in addition to CD4, other cell surface molecules appear to be required for successful HIV entry into and infection of these two human cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293663      PMCID: PMC249089     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS. 3. DETERMINING INFLUENCE OF A NEW HELPER VIRUS ON THE HOST RANGE AND SUSCEPTIBILITY TO INTERFERENCE OF RSV.

Authors:  H HANAFUSA
Journal:  Virology       Date:  1965-02       Impact factor: 3.616

2.  A plaque assay for murine leukemia virus using enzyme-coupled antibodies.

Authors:  B A Nexo
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

3.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

5.  Pseudotyping of dual-tropic recombinant viruses generated by infection of mice with different ecotropic murine leukemia viruses.

Authors:  M Sitbon; J Nishio; K Wehrly; B Chesebro
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

6.  Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses.

Authors:  M Sitbon; J Nishio; K Wehrly; D Lodmell; B Chesebro
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

7.  Phenotypic and genotypic characteristics of a cell line from a squamous cell carcinoma of human skin.

Authors:  P Boukamp; W Tilgen; R T Dzarlieva; D Breitkreutz; D Haag; R K Riehl; A Bohnert; N E Fusenig
Journal:  J Natl Cancer Inst       Date:  1982-03       Impact factor: 13.506

8.  Mechanism of restriction of ecotropic and xenotropic murine leukemia viruses and formation of pseudotypes between the two viruses.

Authors:  P Besmer; D Baltimore
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

9.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

View more
  74 in total

Review 1.  Neurotoxicity of macrophages infected by HIV1.

Authors:  M Tardieu; C Hery; S Peudenier
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

2.  Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2.

Authors:  N Sol; F Ferchal; J Braun; O Pleskoff; C Tréboute; I Ansart; M Alizon
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.

Authors:  P R Clapham; A McKnight; R A Weiss
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  A CRISPR/Cas9 library to map the HIV-1 provirus genetic fitness.

Authors:  K E Yoder
Journal:  Acta Virol       Date:  2019       Impact factor: 1.162

5.  Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses.

Authors:  P Emau; H M McClure; M Isahakia; J G Else; P N Fultz
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  Isolation and characterization of human immunodeficiency virus type 1 variants infectious to brain-derived cells: detection of common point mutations in the V3 region of the env gene of the variants.

Authors:  N S Shimizu; N G Shimizu; Y Takeuchi; H Hoshino
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 7.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

8.  Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.

Authors:  N R Landau; K A Page; D R Littman
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1.

Authors:  J E Merrill; Y Koyanagi; J Zack; L Thomas; F Martin; I S Chen
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.

Authors:  L Bergeron; N Sullivan; J Sodroski
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.